Baxter International Inc. News Headlines

BAX 
$73.46
*  
0.01
 negative 
0.01%
Get BAX Alerts
*Delayed - data as of Apr. 17, 2014 9:30 ET 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    BAX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Baxter Reports Strong First Quarter Financial Results Exceeding Expectations and Confirms 2014 Full-Year Guidance
4/17/2014 7:00:00 AM - Business Wire

Baxter Meets Primary Efficacy Endpoint in Phase 3 Trial of BAX 111, Investigational Stand-Alone Recombinant Treatment for von Willebrand Disease
4/16/2014 8:48:00 AM - Business Wire

Forthcoming Earnings Release Calendar -- Research on AutoNation, Baxter Intl., Cepheid, and BlackRock
4/10/2014 11:04:00 AM - PR Newswire

Baxter Addresses Community Needs Through Charitable Giving and Educational Partnerships
4/10/2014 9:00:00 AM - Business Wire

Baxter International First Quarter 2014 Financial Results Conference Call
4/3/2014 4:15:00 PM - Business Wire

Baxter to Acquire Chatham Therapeutics
4/2/2014 9:00:00 AM - Business Wire

Business Plans, Clinical Trial Results, Meetings, Conferences, and Sponsorships - Analyst Notes on Baxter, Halozyme, WellCare, PDL BioPharma, and Lannett
4/1/2014 8:00:00 AM - PR Newswire

Fitch Places Baxter International Inc.'s Ratings on Negative Watch
3/27/2014 6:03:00 PM - Business Wire

Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
3/27/2014 7:30:00 AM - Business Wire

Approved Equities, Voluntary Recall, and New Product Launches - Analyst Notes on Baxter, Agilent, InterMune, Intuitive Surgical, and Mindray
3/14/2014 8:00:00 AM - PR Newswire

Baxter to Present at Barclay’s Global Healthcare Conference
2/27/2014 4:15:00 PM - Business Wire

Baxter Presents Data at EAHAD from Long-Term Outcomes Registry Reinforcing Prophylaxis Treatment Experience with ADVATE
2/27/2014 9:00:00 AM - Business Wire

Baxter Declares Quarterly Dividend
2/18/2014 9:00:00 AM - Business Wire

Baxter to Present at Cowen & Company’s 34th Annual Health Care Conference
2/13/2014 4:15:00 PM - Business Wire

Baxter to Present at Upcoming Global Healthcare Conferences
2/10/2014 4:15:00 PM - Business Wire

Baxter Announces Restructured Agreement with Xenetic Biosciences, Further Bolstering Its Broad Bleeding Disorder Pipeline
1/30/2014 7:15:00 AM - Business Wire

Baxter Reports Fourth Quarter 2013 Financial Results in Line with Expectations
1/23/2014 7:00:00 AM - Business Wire